Company Overview - Beta Bionics, Inc. is a commercial-stage medical device company focused on developing innovative solutions for insulin-requiring individuals with diabetes [3] - The company utilizes advanced adaptive closed-loop algorithms to enhance diabetes treatment and improve the health and quality of life for people with diabetes [3] - The iLet Bionic Pancreas is the first FDA-cleared insulin delivery device that autonomously determines insulin doses, aiming to improve overall outcomes for a broad population of people with diabetes [3] Upcoming Event - Management will present at the Bank of America Securities Health Care Conference in Las Vegas on May 13, 2025, at 12:35 pm Eastern Time [1] - A live audio webcast of the presentation will be available on the company's website and archived for future replay [2]
Beta Bionics to Present at the Bank of America Securities Health Care Conference